This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Carnevale: Cramer Likes CVS Caremark -- And So Do I

NEW YORK ( F.A.S.T. Graphs) -- Jim Cramer made a bullish call on CVS Caremark (CVS - Get Report) during the lightning round of his Mad Money TV program March 13. Based on the company's fundamentals and fair valuation, I believe Cramer made the right call.

CVS Caremark has a consistent record of above-average earnings growth. Since calendar year 2003, operating earnings have increased at an above-average annual compounded rate of 14.4%. During this time, the stock price has tracked earnings closely.

The following F.A.S.T. Graphs reveals CVS Caremark's highly correlated earnings and price record. Moreover, the company is attractive as it is trading at its earnings-justified valuation level. Add in the 1.7% dividend yield and consider that the dividend has increased every year since 2003 at an average growth rate of 18% per annum, and a long-term investment in CVS Caremark looks attractive.

CVS Caremark has a terrific long-term performance record in which shareholders have been lavishly rewarded. Total cumulative dividend income has been about the same as the S&P 500. However, capital appreciation of 15.2% a year is significantly higher than the 5.8% on the S&P 500.

The consensus of leading analysts following CVS Caremark expect the company to continue to grow at over 13% annually for the next five years. If that happens, the five-year estimated total return, including dividends, would total 14.5% a year. This number is consistent with the company's historical long-term record and, therefore, it's plausible.

CVS Caremark is a well-run drug retailer and a dominant player in its industry. The company generates strong cash flow, is financially strong with a debt-to-capital ratio of only 20%, and operates in a high-growth business. Low valuation, growing dividend yield and strong fundamentals available at attractive valuations support a bullish call on CVS Caremark.

At the time of publication the author had no position in any of the stocks mentioned.

This article was written by an independent contributor, separate from TheStreet's regular news coverage.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CVS $104.24 0.31%
AAPL $94.17 -1.10%
FB $118.16 0.62%
GOOG $699.18 0.99%
TSLA $228.08 -1.80%


Chart of I:DJI
DOW 17,667.90 -83.01 -0.47%
S&P 500 2,051.99 -11.38 -0.55%
NASDAQ 4,731.53 -31.6940 -0.67%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs